抗痘化妆品市场－全球产业规模、份额、趋势、机会和预测：按类型、最终用户、配方、分销管道、地区和竞争格局划分，2021-2031年

全球抗痘化妆品市场预计将从 2025 年的 58.6 亿美元成长到 2031 年的 97.5 亿美元，复合年增长率为 8.86%。

从洗面乳、乳液到局部治疗产品，这些专业的皮肤科产品利用类视色素和水杨酸等活性成分，疏通毛孔，减轻寻常性痤疮引起的发炎。推动市场成长的主要因素是成人和青少年痤疮发病率的不断上升，以及人们对护肤品日益增长的心理依赖（这种依赖性体现在对自信心的提升上），从而促使人们定期使用护肤品。这种需求凸显了保养品在美容产业的重要性，2024年欧洲化妆品协会（Cosmetics Europe）的数据也印证了这一点，数据显示，护肤仍将是欧洲市场的主导品类，零售额将达到301亿欧元。

然而，市场上存在着与治疗顽固性痤疮所需的强效化学成分潜在副作用相关的重大挑战。过度干燥、光敏感和皮肤刺激等反应十分常见，导致消费者难以坚持治疗方案，并可能损害品牌声誉。这项挑战迫使製造商探索复杂的配方策略，以平衡耐受性和疗效。因此，这种需求可能会阻碍产品创新的步伐，并限制产品在敏感肌肤人群中的市场扩张。

市场驱动因素

全球各年龄层人群寻常性痤疮发病率的不断上升，是推动市场成长的主要动力，促使消费者从普通化妆品转向经临床检验的皮肤科治疗产品。随着青春痘日益影响成年人和青少年，消费者对采用高效成分（如硫胺素和水杨酸）且疗效显着的科学配方产品的需求也随之飙升。这种向医用级护肤的转变，为专注于治疗方案的公司带来了可观的收入。例如，拜尔斯道夫于2024年2月发布的2023年度报告指出，该公司皮肤科业务部门（旗下拥有丝胺酸净肤祛痘系列）实现了24.0%的有机销售增长，这表明消费者在面对顽固性皮肤问题时，更注重产品的功效而非外观效果。

同时，直销通路和电商平台的扩张正在打破地理限制，并改变消费者的购买行为。这些数位生态系统使品牌能够绕过传统零售壁垒，提供全面的产品教育和个人化诊断，帮助消费者建立有效的痤疮治疗方案。市场领导的表现充分体现了这种数位转型的规模。欧莱雅在2024年2月发布的「2023财年业绩」中，电商销售额占集团总销售额的27%，凸显了该通路在分销中的重要性。这种管道的拓展正在增强专业护肤领域的财务实力。高德美在2024年2月发布的「2023财年业绩」中，净销售额达到创纪录的40.82亿美元，印证了皮肤科领域的强劲经济效益。

市场挑战

全球抗痘化妆品市场面临的主要障碍之一是强效化学配方带来的不良副作用，这限制了消费者的广泛接受度，并阻碍了他们坚持使用。过氧化苯甲酰和类视色素等关键活性成分常会引起红斑、光敏感和皮肤刺激等副作用。这些不适体验往往导致消费者放弃治疗方案，造成客户维繫率低，且不愿购买后续产品。这构成了市场成长的一大障碍，因为部分人口由于担心损害皮肤健康而对使用经临床验证的解决方案犹豫不决。

由于耐受性问题，潜在市场规模庞大，却仍未充分满足，这进一步凸显了这项挑战的重要性。当配方过于刺激，不适合日常使用时，产业就难以触及需要长期治疗的庞大族群。鑑于痤疮的普遍性，这种情况意味着巨大的经济损失。根据2024年美国皮肤病学会的数据，痤疮是美国最常见的皮肤病，每年影响多达5,000万人。因此，产品功效与消费者耐受性之间的差距直接限制了市场充分利用这个庞大患者群体的能力。

市场趋势

创新剂型的出现，尤其是微针贴片，正在改变全球抗痘化妆品市场，为消费者提供了卫生、精准的替代方案，取代了传统的全脸乳霜。这一趋势满足了消费者对便捷易用型治疗方法日益增长的需求，这些产品能够隔离痘痘，促进癒合，同时限制细菌扩散，标誌着消费者正在从传统的预防性护理方式转向更高效的祛痘产品。这些隐藏的微针和亲水胶体配方产品的快速普及，正为被大型公司收购的专业品牌带来显着的财务成长动力。例如，Church & Dwight 在 2025 年 1 月发布的「2024 财年第四季及全年报告」中指出，其国内消费品部门的净销售额增长了 2.7%，达到 12.257 亿美元。其中，「Hero」祛痘产品线的成长尤为显着，推动了该部门对整体市场业绩的贡献。

同时，业界正日益关注痤疮后皮肤屏障修復和疤痕管理，消费者的关注点也从痤疮本身转向皮肤健康的长期修復。製造商积极采用先进的生物技术成分，旨在强化皮肤屏障并减少发炎后色素沉着，从而吸引那些关注痤疮长期影响的用户。这种向修復和补救护理的策略转变，有效地将皮肤科品牌的影响力扩展到了治疗后的阶段。根据拜尔斯道夫于2025年2月发布的2024年度报告，其皮肤科业务部门实现了10.6%的有机销售额成长，达到14亿欧元。这项业绩主要得益于Thiamidol产品线的扩张，该产品线是一种专门针对痤疮肌肤常见色素沉着问题的成分。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球抗痘化妆品市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按类型（面膜、洗面乳、乳霜/乳液、洗面乳/化妆水、其他）
  • 按最终用户（男性、女性）
  • 按配方（有机、无机）
  • 依分销管道（百货公司、超级市场/大卖场、药局/药局、专卖店、线上、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美抗痘化妆品市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

第七章 欧洲抗痘化妆品市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区抗痘化妆品市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲抗痘化妆品市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲抗痘化妆品市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球抗痘化妆品市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• L'Oreal Paris
• Murad LLC
• Neutrogena
• Clinique Laboratories, LLC
• Vichy Laboratories
• PCA Skin
• Obaji
• Skin Medica
• Skin Better Science
• Colorescience

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Anti-Acne Cosmetics Market is projected to expand from USD 5.86 Billion in 2025 to USD 9.75 Billion by 2031, registering a CAGR of 8.86%. These specialized dermatological products, ranging from cleansers and emulsions to spot treatments, employ active ingredients like retinoids and salicylic acid to clear pores and alleviate inflammation associated with acne vulgaris. Growth is primarily propelled by the increasing prevalence of acne in both adults and adolescents, alongside a psychological reliance on skincare for self-esteem, which encourages regular product application. This demand highlights the sector's importance within the beauty industry, a fact supported by Cosmetics Europe data from 2024, which noted that skin care remained the leading category in the European market with retail sales totaling €30.1 billion.

However, the market faces significant hurdles related to the potential adverse effects of strong chemical ingredients required to treat stubborn acne. Reactions such as excessive dryness, photosensitivity, and skin irritation frequently deter consumers from adhering to treatment plans, which can subsequently tarnish brand reputation. This challenge compels manufacturers to navigate complex formulation strategies to achieve a balance between tolerability and efficacy. Consequently, this necessity can hinder the pace of product innovation and restrict market reach among demographics with sensitive skin.

Market Driver

The escalating global incidence of acne vulgaris across all age groups serves as a primary growth engine, prompting a consumer shift from general cosmetic products to clinically validated dermatological treatments. As acne increasingly impacts adults as well as adolescents, there is a surge in demand for science-based formulations that utilize high-performance ingredients such as thiamidol and salicylic acid to ensure results. This movement towards medical-grade skincare is generating significant revenue for companies focused on therapeutic solutions. For instance, Beiersdorf's 'Annual Report 2023', released in February 2024, highlighted that its Derma business unit-home to the Eucerin DermoPurifyer acne line-achieved organic sales growth of 24.0%, illustrating that consumers are prioritizing functional performance over aesthetic enhancement for persistent skin issues.

Concurrently, the expansion of direct-to-consumer channels and e-commerce platforms is removing geographical limitations and transforming purchasing behaviors. These digital ecosystems enable brands to bypass traditional retail barriers by providing extensive product education and personalized diagnostics that assist consumers in establishing effective anti-acne routines. The scale of this digital transition is evident in the results of market leaders; L'Oreal's '2023 Annual Results' from February 2024 indicated that e-commerce contributed 27% of total Group sales, emphasizing the channel's vital role in distribution. This improved accessibility bolsters the financial strength of the specialized skincare sector, as confirmed by Galderma's 'Full Year 2023 Results' in February 2024, which reported record net sales of USD 4,082 million, validating the robust economic magnitude of the dermatological category.

Market Challenge

A distinct hurdle for the Global Anti-Acne Cosmetics Market involves the adverse side effects associated with potent chemical formulations, which limit widespread consumer adoption and disrupt consistent usage. Essential efficacy ingredients, such as benzoyl peroxide and retinoids, often trigger negative reactions including erythema, photosensitivity, and skin irritation. These adverse experiences frequently drive consumers to abandon treatment regimens prematurely, leading to reduced customer retention and a hesitation to buy follow-up products. This dynamic presents a substantial obstacle to growth, as the fear of compromising skin health prevents a significant portion of the population from utilizing clinically proven solutions.

The significance of this challenge is amplified by the sheer size of the addressable market that remains underserved due to these tolerability concerns. When formulations are too harsh for regular application, the industry struggles to capture the vast demographic that requires long-term management. This represents a considerable loss of economic potential given the ubiquity of the condition; according to the American Academy of Dermatology in 2024, acne was the most prevalent skin condition in the United States, affecting up to 50 million individuals annually. Consequently, the gap between product potency and consumer tolerance directly restricts the market's capacity to fully monetize this extensive patient base.

Market Trends

The emergence of innovative delivery formats, particularly microneedle patches, is transforming the Global Anti-Acne Cosmetics Market by providing consumers with hygienic, targeted alternatives to conventional full-face creams. This trend meets the rising demand for convenient, on-the-go treatments that isolate blemishes to speed up healing while curbing bacterial spread, representing a clear departure from traditional preventative routines. The rapid mass adoption of these discreet microneedle and hydrocolloid solutions has created significant financial momentum for specialized brands recently acquired by major corporations. For example, Church & Dwight Co., Inc. reported in their 'Fourth Quarter and Full Year 2024 Results' in January 2025 that their Consumer Domestic segment saw net sales rise by 2.7% to $1,225.7 million, with growth specifically driven by Hero acne products, confirming the segment's vital contribution to overall market performance.

In parallel, the industry is experiencing a growing emphasis on post-acne barrier repair and scar management, shifting consumer focus from active breakouts to the long-term restoration of skin integrity. Manufacturers are increasingly utilizing advanced biotechnological ingredients to strengthen the skin barrier and mitigate post-inflammatory hyperpigmentation, appealing to users worried about the lasting visual effects of acne. This strategic shift toward restorative and corrective care is effectively extending the reach of dermatological brands into the post-treatment stage. As noted in Beiersdorf's 'Annual Report 2024' from February 2025, the Derma business unit achieved organic sales growth of 10.6%, reaching €1.4 billion, a performance largely driven by the expansion of the Thiamidol ingredient range, which specifically addresses pigmentation concerns common in acne-prone skin.

Key Market Players

• L'Oreal Paris
• Murad LLC
• Neutrogena
• Clinique Laboratories, LLC
• Vichy Laboratories
• PCA Skin
• Obaji
• Skin Medica
• Skin Better Science
• Colorescience

Report Scope

In this report, the Global Anti-Acne Cosmetics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anti-Acne Cosmetics Market, By Type

• Masks
• Face Wash
• Creams & Lotions
• Cleanser & Toner
• Others

Anti-Acne Cosmetics Market, By End User

• Men
• Women

Anti-Acne Cosmetics Market, By Formulation

• Organic
• Inorganic

Anti-Acne Cosmetics Market, By Distribution Channel

• Departmental Store
• Supermarkets/Hypermarkets
• Drug/Pharmacy Stores
• Exclusive Stores
• Online
• Others

Anti-Acne Cosmetics Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Anti-Acne Cosmetics Market.

Available Customizations:

Global Anti-Acne Cosmetics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Anti-Acne Cosmetics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Masks, Face Wash, Creams & Lotions, Cleanser & Toner, Others)
  • 5.2.2. By End User (Men, Women)
  • 5.2.3. By Formulation (Organic, Inorganic)
  • 5.2.4. By Distribution Channel (Departmental Store, Supermarkets/Hypermarkets, Drug/Pharmacy Stores, Exclusive Stores, Online, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Anti-Acne Cosmetics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End User
  • 6.2.3. By Formulation
  • 6.2.4. By Distribution Channel
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Anti-Acne Cosmetics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End User
      • 6.3.1.2.3. By Formulation
      • 6.3.1.2.4. By Distribution Channel
  • 6.3.2. Canada Anti-Acne Cosmetics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End User
      • 6.3.2.2.3. By Formulation
      • 6.3.2.2.4. By Distribution Channel
  • 6.3.3. Mexico Anti-Acne Cosmetics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End User
      • 6.3.3.2.3. By Formulation
      • 6.3.3.2.4. By Distribution Channel

7. Europe Anti-Acne Cosmetics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End User
  • 7.2.3. By Formulation
  • 7.2.4. By Distribution Channel
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Anti-Acne Cosmetics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End User
      • 7.3.1.2.3. By Formulation
      • 7.3.1.2.4. By Distribution Channel
  • 7.3.2. France Anti-Acne Cosmetics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End User
      • 7.3.2.2.3. By Formulation
      • 7.3.2.2.4. By Distribution Channel
  • 7.3.3. United Kingdom Anti-Acne Cosmetics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End User
      • 7.3.3.2.3. By Formulation
      • 7.3.3.2.4. By Distribution Channel
  • 7.3.4. Italy Anti-Acne Cosmetics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End User
      • 7.3.4.2.3. By Formulation
      • 7.3.4.2.4. By Distribution Channel
  • 7.3.5. Spain Anti-Acne Cosmetics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End User
      • 7.3.5.2.3. By Formulation
      • 7.3.5.2.4. By Distribution Channel

8. Asia Pacific Anti-Acne Cosmetics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End User
  • 8.2.3. By Formulation
  • 8.2.4. By Distribution Channel
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Anti-Acne Cosmetics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End User
      • 8.3.1.2.3. By Formulation
      • 8.3.1.2.4. By Distribution Channel
  • 8.3.2. India Anti-Acne Cosmetics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End User
      • 8.3.2.2.3. By Formulation
      • 8.3.2.2.4. By Distribution Channel
  • 8.3.3. Japan Anti-Acne Cosmetics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End User
      • 8.3.3.2.3. By Formulation
      • 8.3.3.2.4. By Distribution Channel
  • 8.3.4. South Korea Anti-Acne Cosmetics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End User
      • 8.3.4.2.3. By Formulation
      • 8.3.4.2.4. By Distribution Channel
  • 8.3.5. Australia Anti-Acne Cosmetics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End User
      • 8.3.5.2.3. By Formulation
      • 8.3.5.2.4. By Distribution Channel

9. Middle East & Africa Anti-Acne Cosmetics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End User
  • 9.2.3. By Formulation
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Anti-Acne Cosmetics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End User
      • 9.3.1.2.3. By Formulation
      • 9.3.1.2.4. By Distribution Channel
  • 9.3.2. UAE Anti-Acne Cosmetics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End User
      • 9.3.2.2.3. By Formulation
      • 9.3.2.2.4. By Distribution Channel
  • 9.3.3. South Africa Anti-Acne Cosmetics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End User
      • 9.3.3.2.3. By Formulation
      • 9.3.3.2.4. By Distribution Channel

10. South America Anti-Acne Cosmetics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By End User
  • 10.2.3. By Formulation
  • 10.2.4. By Distribution Channel
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Anti-Acne Cosmetics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End User
      • 10.3.1.2.3. By Formulation
      • 10.3.1.2.4. By Distribution Channel
  • 10.3.2. Colombia Anti-Acne Cosmetics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End User
      • 10.3.2.2.3. By Formulation
      • 10.3.2.2.4. By Distribution Channel
  • 10.3.3. Argentina Anti-Acne Cosmetics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End User
      • 10.3.3.2.3. By Formulation
      • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Anti-Acne Cosmetics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. L'Oreal Paris
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Murad LLC
• 15.3. Neutrogena
• 15.4. Clinique Laboratories, LLC
• 15.5. Vichy Laboratories
• 15.6. PCA Skin
• 15.7. Obaji
• 15.8. Skin Medica
• 15.9. Skin Better Science
• 15.10. Colorescience

16. Strategic Recommendations

17. About Us & Disclaimer